Skip to the page

Data / Form D filings / PushCART Therapeutics, Inc.

PushCART Therapeutics, Inc.: Form D filing

PushCART Therapeutics, Inc., a biotechnology company in Rockville, MD, filed a Form D with the SEC in 2026. The latest, on July 31, 2026, reports $500,000 sold of a $2 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1 CHURCH ST. #801, Rockville, MD, 20850
Phone
(301) 637-7950
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2147621

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 31, 2026New notice$2,000,000$500,000$1,500,0001Jul 10, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephen D. WolpeExecutive Officer, Director
Louis M. WeinerDirector
Sean ReinekeDirector
Albert HawkDirector

Other biotechnology companies in Maryland that filed recently

Every Form D from the week of Jul 27, 2026 · All recent filings in Maryland · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what PushCART Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.